Daily Sepsis Research Analysis
Analyzed 17 papers and selected 3 impactful papers.
Summary
A single-center RCT found that renal resistive index (RRI)-guided mean arterial pressure titration improved renal hemodynamics but did not reduce 28-day mortality in sepsis. A two-center prospective study showed passive leg raising loses accuracy under intra-abdominal hypertension, while end-expiratory occlusion and mini-fluid challenge remain reliable. A PROSPERO-registered meta-analysis confirmed rapid blood-culture-based molecular diagnostics deliver near-perfect accuracy and markedly faster pathogen identification.
Research Themes
- Physiology-guided hemodynamic targets in sepsis
- Fluid responsiveness assessment under intra-abdominal hypertension
- Rapid molecular diagnostics to accelerate antimicrobial optimization
Selected Articles
1. Renal resistive index-guided mean arterial pressure titration in sepsis: a prospective single-center, single-blind, parallel-group randomized controlled trial.
In this single-center RCT (n=274), RRI-guided MAP titration improved renal resistive index compared with usual care but did not reduce 28-day mortality (RR 0.69; 95% CI 0.44–1.08). The trial supports that physiologic optimization of renal perfusion indices alone may not translate into survival benefit.
Impact: Provides high-quality randomized evidence clarifying that an RRI-guided hemodynamic strategy does not improve survival, tempering enthusiasm for organ-specific MAP targets in sepsis.
Clinical Implications: Do not adopt RRI-guided MAP titration solely to reduce mortality in sepsis. Consider RRI as a renal hemodynamics tool rather than a mortality-targeting strategy; future protocols should evaluate patient selection and kidney-centered outcomes.
Key Findings
- RRI decreased significantly after titration in the intervention group vs control (0.61 vs 0.67; P<0.001).
- No significant reduction in 28-day all-cause mortality (25/138 vs 36/136; RR 0.69, 95% CI 0.44–1.08; P=0.11).
- Single-center, single-blind RCT suggests improved renal hemodynamics did not translate into survival benefit.
Methodological Strengths
- Randomized, single-blind, parallel-group design with prospective registry (ChiCTR2200057136).
- Predefined primary endpoint and standardized physiologic assessment (RRI).
Limitations
- Single-center design may limit generalizability.
- Potentially underpowered to detect modest mortality effects; external replication lacking.
Future Directions: Multicenter RCTs assessing personalized MAP targets incorporating renal and systemic perfusion metrics, with kidney-specific endpoints and cost–benefit analyses.
In sepsis, optimizing mean arterial pressure (MAP) for organ perfusion remains challenging. We conduct a single-center, single-blind, parallel-group randomized controlled trial enrolling 274 sepsis patients to evaluate whether renal resistive index (RRI)-guided MAP titration (MAP titration group, MTG) reduces 28-day all-cause mortality (primary endpoint) compared with conventional treatment (conventional treatment group, CTG). Post-titration, RRI decreases significantly in the MTG versus CTG (0.61 vs. 0.67, P < 0.001). However, 28-day mortality does not differ (25/138 vs. 36/136; RR 0.69, 95% CI 0.44-1.08; P = 0.11). These findings suggest that RRI-guided MAP titration improves renal hemodynamics but does not reduce mortality in this single-center trial; multicenter confirmation is warranted. (Chinese Clinical Trial Registry, ChiCTR2200057136, registered 1 March 2022; https://www.chictr.org.cn/showprojEN.html?proj=153154).
2. Assessing fluid responsiveness in mechanically ventilated patients with intra-abdominal hypertension: a two-center, prospective, observational study.
Among 88 ventilated ICU patients, PLR accuracy fell markedly in IAH (AUROC 0.71) versus non-IAH (0.96), linked to persistently negative CVP–IAP gradients. EEO and a 100-mL mini-fluid challenge retained high and comparable accuracy irrespective of IAH status.
Impact: Clarifies a common diagnostic pitfall by mechanistically explaining PLR failure in IAH and offers immediately applicable alternatives (EEO and mini-fluid challenge).
Clinical Implications: In suspected or measured IAH, avoid relying on PLR to guide fluids; prefer EEO or mini-fluid challenge and consider CVP–IAP gradients to interpret preload responsiveness.
Key Findings
- PLR AUROC dropped from 0.96 (no IAH) to 0.71 (IAH) for fluid responsiveness (p=0.009).
- EEO and 100-mL mini-fluid challenge maintained high accuracy regardless of IAH (EEO AUROC 0.95 vs 0.89; mini-fluid 0.94 vs 0.90).
- Negative baseline CVP–IAP gradients explained PLR false-negatives; gradient reversal occurred only in true-positives.
Methodological Strengths
- Prospective two-center design with transpulmonary thermodilution to measure cardiac index.
- Standardized sequential maneuvers (PLR, EEO, mini-fluid challenge) and prespecified AUROC analyses.
Limitations
- Modest sample size and physiologic endpoints limit power for clinical outcomes.
- Findings may not generalize to spontaneously breathing patients or arrhythmias.
Future Directions: Validate EEO/mini-fluid challenge algorithms in larger, diverse IAH populations and integrate CVP–IAP gradients into bedside decision support.
BACKGROUND: Intra-abdominal hypertension (IAH) may reduce the diagnostic accuracy of the passive leg raising (PLR) test for predicting fluid responsiveness, with unclear mechanisms. The reliability of the end-expiratory occlusion (EEO) test and mini-fluid challenge in IAH remains unknown. This study explored the mechanisms underlying PLR impairment and assessed the accuracy of EEO and mini-fluid challenge in detecting fluid responsiveness in patients with and without IAH. METHODS: In this prospective study in two intensive care units (ICUs), we included ventilated patients with IAH ("IAH + "; intra-abdominal pressure [IAP] ≥ 12 mmHg) and without ("IAH-"), all monitored via transpulmonary thermodilution and receiving a 500-mL fluid challenge. Patients consecutively underwent a 1‑minute PLR, a 15‑second EEO, and a 1‑minute mini-fluid challenge of 100 mL, with cardiac index (CI) changes recorded during each maneuver. Following the mini-fluid challenge, the remaining 400 mL were infused over 14 min, and a ≥ 15% increase in CI was used to define fluid responders. The transmural pressure of the inferior vena cava was estimated by the central venous pressure (CVP) - IAP gradient. RESULTS: We included 88 patients, 44 IAH- (25 fluid responders and 19 non-responders) and 44 IAH + (22 responders and 22 non-responders). Baseline IAP was 9 ± 2 mmHg in IAH- and 17 ± 3 mmHg in IAH + (p < 0.001). In IAH- responders, CI increased by 19 ± 11% during PLR and 31 ± 17% after volume expansion, with PLR positive in 24/25 responders. In IAH + responders, CI increased by 6 ± 7% during PLR (p < 0.001 vs. IAH-) and 30 ± 18% after volume expansion (p = 0.907 vs. IAH-). The AUROC of the PLR for detecting fluid responsiveness was 0.96 (0.87-1.00) in IAH- and 0.71 (0.56-0.87) in IAH + (p = 0.009 vs. IAH-). Among IAH + , there were 16 false negatives and 6 true positives for PLR, both with negative baseline CVP-IAP gradients. During PLR, the gradient reversed in true-positives (from -2.4 ± 4.0 to + 2.2 ± 2.7 mmHg, p = 0.014), whereas it remained negative in false-negatives (from -6.3 ± 3.7 to -1.4 ± 3.4 mmHg, p < 0.001). AUROC between IAH- and IAH + was similar for either the EEO test (0.95 [0.87-1.00] vs. 0.89 [0.80-0.97], p = 0.332) or mini-fluid challenge (0.94 [0.87-1.00] vs. 0.90 [0.79-1.00], p = 0.514). CONCLUSION: In patients with IAH, the limited diagnostic value of PLR for fluid responsiveness may be related to persistently negative CVP-IAP gradients in false-negative cases, whereas EEO and mini-fluid challenge remain reliable alternatives.
3. Evaluating Rapid Diagnostics for Severe Infections and Sepsis: A Systematic Review and Meta-analysis on behalf of the Hellenic Microbiological Society and the Hellenic Society of Chemotherapy.
This PROSPERO-registered meta-analysis shows rapid molecular tests from blood (often positive blood cultures) achieve pooled sensitivity ~0.97–0.98 and specificity ~0.99–1.00 across major pathogen groups, and reduce time to identification by about 21 hours. Findings support integrating rapid diagnostics into sepsis pathways to expedite antimicrobial optimization.
Impact: Synthesizes a large body of evidence demonstrating both excellent diagnostic accuracy and clinically meaningful time savings, informing antimicrobial stewardship and sepsis bundles.
Clinical Implications: Adopt rapid blood-culture-based molecular diagnostics within sepsis workflows alongside stewardship to shorten time to organism identification and alignment of antimicrobial therapy.
Key Findings
- Pooled bivariate sensitivity ~0.97–0.98 and specificity ~0.99–1.00 for pathogen identification across Gram-negative, Gram-positive, and yeasts.
- Rapid diagnostics shortened time to pathogen identification by an average of 21.43 hours (95% CI -29.15 to -13.72; P<0.0001).
- Clinical outcomes assessed included time to optimal therapy, 30-day mortality, and costs, supporting system-level integration.
Methodological Strengths
- Prospectively registered protocol (PROSPERO) with comprehensive multi-database search.
- Random-effects meta-analysis and bivariate models for diagnostic accuracy.
Limitations
- Heterogeneity in study designs and settings; inclusion of both RCTs and observational studies.
- Potential publication bias and variable reporting of clinical endpoints.
Future Directions: Randomized implementation trials linking rapid diagnostics to patient-centered outcomes and antimicrobial stewardship metrics, including cost-effectiveness analyses.
BACKGROUND: The diagnostic accuracy and clinical benefit of molecular methods for pathogen identification and antimicrobial susceptibility testing were assessed through a systematic review and meta-analysis. METHODS: The protocol was prospectively registered with PROSPERO (CRD420251044218). A comprehensive search of MEDLINE (via PubMed), the Cochrane Library, and ClinicalTrials.gov was conducted to identify randomized controlled trials, non-controlled trials, and observational studies. The review investigated rapid diagnostic tests performed on blood samples for pathogen identification and susceptibility testing. The primary outcomes were Diagnostic Test Accuracy (DTA) for microbiological evaluation and time to pathogen identification, as well as to optimal/ adjusted/ appropriate antimicrobial treatment for clinical assessment. Secondary outcomes included 30-day mortality and total hospitalization cost. A random-effects model was used for quantitative synthesis. RESULTS: Of 1353 articles retrieved, 49 and 33 records were included in microbiological and clinical analysis. Pooled bivariate sensitivity for pathogen identification ranged from 0.97 to 0.98 (95% CIs approximately 0.94-0.99), with specificity consistently 0.99-1.00 across Gram-negative bacteria, Gram-positive bacteria, and yeasts. The mean time difference for pathogen identification was -21.43 hours (95% CI -29.15 to -13.72; P<0.0001; I CONCLUSION: Evidence indicates that early, actionable diagnostics, particularly those from positive blood cultures, are essential to effective sepsis care.